Iovance Biotherapeutics
Shanna Wu, CPA, is currently working as a Manager, Global Consolidation at Iovance Biotherapeutics, Inc. Shanna previously held positions as a Senior Accountant at the same company and as a Sr. Consultant and Consultant at SD Mayer & Associates LLP. Prior to this, Shanna worked as an Accountant at Ubiquity Retirement + Savings. Shanna Wu graduated from the University of Oregon in 2013 with a Bachelor of Science (B.S.) in Accounting.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.